Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

BACKGROUND: Patients with gastric cancer and peritoneal carcinomatosis have a very poor prognosis; median survival is 3 to 4 months. Palliative systemic chemotherapy is currently the only treatment available in the Netherlands. Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has an...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kaaij, Rosa T, Braam, Hidde JW, Boot, Henk, Los, Maartje, Cats, Annemieke, Grootscholten, Cecile, Schellens, Jan HM, Aalbers, Arend GJ, Huitema, Alwin DR, Knibbe, Catherijne AJ, Boerma, Djamila, Wiezer, Marinus J, van Ramshorst, Bert, van Sandick, Johanna W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532515/
https://www.ncbi.nlm.nih.gov/pubmed/28705789
http://dx.doi.org/10.2196/resprot.7790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532515/
https://www.ncbi.nlm.nih.gov/pubmed/28705789
http://dx.doi.org/10.2196/resprot.7790

Ejemplares similares